ROCHE HLDG LTD SPONS Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (40)

View All

Latest Posts

About This Stock More About This Stock
Regeneron To Collaborate With Roche For Global Supply Of Its Coronavirus Treatment
Article By: Benzinga
Wednesday, August 19, 2020 7:20 AM EDT
Regeneron Pharmaceuticals Inc and Roche Holding AG on Monday disclosed that they are collaborating to develop, manufacture, and distribute the former's COVID-19 antibody cocktail.
In this article: RHHBY, RGEN
Read
E The Global Stocks To Watch
Article By: Vivian Lewis
Monday, August 10, 2020 10:50 PM EDT
Today we a quarterly report and news on the global stocks we have our eyes on.
In this article: CVAC, CAE, NIO, RDS-B, RHHBY, MELI, GOLD, HOLI, MSFT, GLD, TWTR, PYPL, BGNE, KL, AZRE, BDNCE
Read
The Trump Effect: How Trump's Policies Moved Stocks This Past Week
Article By: The Fly
Sunday, August 2, 2020 8:45 AM EDT
Trump says drug prices to be "lowered massively," Chinese-backed hackers reportedly behind Moderna attack.
In this article: L, AZN, BMY, GSK, JNJ, LLY, MRK, NVS, PFE, SNY, RHHBY, AAPL, AMZN, GOOG, MSFT, MRNA, SNAP, FB, TWTR, GOOGL, KODK
Read
Week In Review: Suzhou Innovent Announces $2 Billion Immunotherapy Collaboration With Roche
Article By: ChinaBio® Today
Saturday, June 13, 2020 1:32 PM EDT
Suzhou Innovent Bio formed a far-reaching R&D collaboration with Roche that has a potential value of over $2 billion. Roche will have an option to license each product for ex-China development and commercialization.
In this article: RHHBY Also: LLY, SNY, BRN, JUNO
Read
Drugmakers Test New Ways To Fight Coronavirus: 3 Stocks To Pick Up Now
Article By: Eddy Elfenbein
Tuesday, March 31, 2020 6:24 AM EDT
On September 2011, the world changed. The acts of terrorism in New York, Washington, and Pennsylvania not only destroyed buildings and lives, but changed both what and how we do a number of activities.
In this article: RHHBY, REGN, GILD
Read
All Posts

PARTNER HEADLINES

Latest Tweets for $RHHBY

No tweets yet!